Cheng AL - Search Results

1

Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.

Merle P, Kudo M, Edeline J, Bouattour M, Cheng AL, Chan SL, Yau T, Garrido M, Knox J, Daniele B, Breder V, Lim HY, Ogasawara S, Cattan S, Chao Y, Siegel AB, Martinez-Forero I, Wei Z, Liu CC, Finn RS. Merle P, et al. Among authors: cheng al. Liver Cancer. 2023 Feb 14;12(4):309-320. doi: 10.1159/000529636. eCollection 2023 Sep. Liver Cancer. 2023. PMID: 37901200 Free PMC article.

2

Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.

Hsu C, Huang CS, Chao TY, Lu YS, Bu CF, Chen MM, Chang KJ, Cheng AL. Hsu C, et al. Among authors: cheng al. Cancer. 2002 Nov 15;95(10):2044-50. doi: 10.1002/cncr.10951. Cancer. 2002. PMID: 12412156 Free article. Clinical Trial.

3

Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer.

Shiah HS, Cheng AL, Hsu C, Hsu CH, Liu TW, Chang JY, Jan CM, Chao Y, Yu WL, Chuang TR, Whang-Peng J, Chen LT. Shiah HS, et al. Among authors: cheng al. J Gastroenterol Hepatol. 2006 Mar;21(3):531-6. doi: 10.1111/j.1440-1746.2005.03957.x. J Gastroenterol Hepatol. 2006. PMID: 16638094 Clinical Trial.

4

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.

Shao YY, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL. Shao YY, et al. Among authors: cheng al. Cancer. 2010 Oct 1;116(19):4590-6. doi: 10.1002/cncr.25257. Cancer. 2010. PMID: 20572033 Free article.

5

A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.

Chen JS, Chao Y, Hsieh RK, Cheng AL, Chen PM, Chiou TJ, Chao TY, Yeh KH, Chen LT, Whang-Peng J. Chen JS, et al. Among authors: cheng al. Cancer Chemother Pharmacol. 2011 Jun;67(6):1281-9. doi: 10.1007/s00280-010-1416-8. Epub 2010 Aug 17. Cancer Chemother Pharmacol. 2011. PMID: 20714726 Clinical Trial.

6

Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib.

Faivre S, Zappa M, Vilgrain V, Boucher E, Douillard JY, Lim HY, Kim JS, Im SA, Kang YK, Bouattour M, Dokmak S, Dreyer C, Sablin MP, Serrate C, Cheng AL, Lanzalone S, Lin X, Lechuga MJ, Raymond E. Faivre S, et al. Among authors: cheng al. Clin Cancer Res. 2011 Jul 1;17(13):4504-12. doi: 10.1158/1078-0432.CCR-10-1708. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531821 Clinical Trial.

7

Harmon CS, DePrimo SE, Raymond E, Cheng AL, Boucher E, Douillard JY, Lim HY, Kim JS, Lechuga MJ, Lanzalone S, Lin X, Faivre S. Harmon CS, et al. Among authors: cheng al. J Transl Med. 2011 Jul 25;9:120. doi: 10.1186/1479-5876-9-120. J Transl Med. 2011. PMID: 21787417 Free PMC article. Clinical Trial.

8

Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.

Hsu C, Yang TS, Huo TI, Hsieh RK, Yu CW, Hwang WS, Hsieh TY, Huang WT, Chao Y, Meng R, Cheng AL. Hsu C, et al. Among authors: cheng al. J Hepatol. 2012 May;56(5):1097-1103. doi: 10.1016/j.jhep.2011.12.013. Epub 2012 Jan 13. J Hepatol. 2012. PMID: 22245891 Clinical Trial.

9

Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy.

Shao YY, Huang CC, Lin SD, Hsu CH, Cheng AL. Shao YY, et al. Among authors: cheng al. Clin Cancer Res. 2012 Jul 15;18(14):3992-7. doi: 10.1158/1078-0432.CCR-11-2853. Epub 2012 May 23. Clin Cancer Res. 2012. PMID: 22623732

10

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).

Park JW, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, Han KH, Kudo M, Lee HC, Lee RC, Lesmana LA, Lim HY, Paik SW, Poon RT, Tan CK, Tanwandee T, Teng G, Cheng AL. Park JW, et al. Among authors: cheng al. Liver Int. 2013 Mar;33(3):327-37. doi: 10.1111/liv.12083. Epub 2013 Jan 18. Liver Int. 2013. PMID: 23331661 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

805 results

Search Page